VI
HZNP

Versor Investments’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Versor Investments’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-76,318
Closed -$8.83M – 907
2023
Q3 		$8.83M Sell
76,318
-49,981
-40% -$5.37M 1.79% 4
2023
Q2 		$13M Sell
126,299
-70,928
-36% -$7.48M 2.25% 13
2023
Q1 		$21.5M Sell
197,227
-98,805
-33% -$10.9M 2.82% 8
2022
Q4 		$33.7M Buy
+296,032
New +$24.6M 2.89% 9
2020
Q4 		– Sell
-10,000
Closed -$777K – 314
2020
Q3 		$777K Buy
+10,000
New +$688K 0.07% 103
2020
Q2 		– Sell
-16,300
Closed -$483K – 330
2020
Q1 		$483K Buy
+16,300
New +$551K 0.03% 119
2019
Q1 		– Sell
-14,100
Closed -$276K – 353
2018
Q4 		$276K Buy
14,100
+2,400
+21% +$47K 0.06% 226
2018
Q3 		$229K Buy
+11,700
New +$222K 0.09% 226

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Versor Investments's HZNP Position: Q4 2023 in Review

Versor Investments sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 76,318 shares — an estimated $8.83M sold.

Versor Investments first reported a position in HZNP in Q3 2018 and held it in 8 quarters. The position peaked at $33.7M in Q4 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Versor Investments reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Versor Investments sold 76,318 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $8.83M.
  • Versor Investments first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2018 and held it in 8 quarters.
  • Versor Investments's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $33.7M in Q4 2022.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Versor Investments's 13F filing for Q4 2023, filed 7 Feb 2024.